Weekly Snapshot PharmaShots Weekly Snapshots (May 12, 2025 – May 16, 2025) ByRidhi RastogiMay 16, 20250Comments
News BioCryst Reports the US FDA’s NDA Acceptance and Priority Review of Orladeyo for Hereditary Angioedema (HAE)ByRidhi RastogiMay 16, 20250Comments
News Travere Therapeutics Reports the US FDA’s sNDA Acceptance of Filspari for Focal Segmental Glomerulosclerosis (FSGS)ByRidhi RastogiMay 16, 20250Comments
News The US FDA Approves Incyte’s Zynyz to Treat Adults with Squamous Cell Anal Carcinoma (SCAC)ByRidhi RastogiMay 16, 20250Comments
News Rznomics Partners with Eli Lilly for RNA Editing TherapeuticsByDipanshu DixitMay 16, 20250Comments
News ArkBio Reports P-II Study Data Evaluating AK3280 to Treat Idiopathic Pulmonary Fibrosis (IPF)ByPrince GiriMay 16, 20250Comments
News AbbVie’s Emrelis Receives the US FDA’s Accelerated Approval for NSCLC With High c-Met Protein OverexpressionByRidhi RastogiMay 16, 20250Comments